Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Niland

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Clinical Immunology and Immunopathology|July 1, 1989
Immunophenotyping in a multicenter study: the Transfusion Safety Study experienceM A Fletcher, S P Azen, B Adelsberg, et al.
Annals of Internal Medicine|November 15, 1990
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donationsE Donegan, M Stuart, J C Niland, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study GroupD J Lang, A A Kovacs, J A Zaia, et al.
The New England Journal of Medicine|October 21, 1993
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host diseaseN J Chao, G M Schmidt, J C Niland, et al.
Transplantation|March 1, 1993
Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of lifeG M Schmidt, J C Niland, S J Forman, et al.
Transfusion|September 1, 1989
Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor RepositoryS H Kleinman, J C Niland, S P Azen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 1995
Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-upJ A Zaia, G M Schmidt, N J Chao, et al.
Clinical Transplantation|September 2, 2009
Validation of methodologies for quantifying isolated human islets: an Islet Cell Resources studyH J Kissler, J C Niland, B Olack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemiaS J Forman, G M Schmidt, A P Nademanee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Solid cancers after bone marrow transplantationS Bhatia, A D Louie, R Bhatia, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical Immunology and Immunopathology|July 1, 1989
Immunophenotyping in a multicenter study: the Transfusion Safety Study experienceM A Fletcher, S P Azen, B Adelsberg, et al.
Annals of Internal Medicine|November 15, 1990
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donationsE Donegan, M Stuart, J C Niland, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study GroupD J Lang, A A Kovacs, J A Zaia, et al.
The New England Journal of Medicine|October 21, 1993
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host diseaseN J Chao, G M Schmidt, J C Niland, et al.
Transplantation|March 1, 1993
Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Issues of quality of lifeG M Schmidt, J C Niland, S J Forman, et al.
Transfusion|September 1, 1989
Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor RepositoryS H Kleinman, J C Niland, S P Azen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 1995
Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-upJ A Zaia, G M Schmidt, N J Chao, et al.
Clinical Transplantation|September 2, 2009
Validation of methodologies for quantifying isolated human islets: an Islet Cell Resources studyH J Kissler, J C Niland, B Olack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemiaS J Forman, G M Schmidt, A P Nademanee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Solid cancers after bone marrow transplantationS Bhatia, A D Louie, R Bhatia, et al.
Pageof 4